Clinical Trials Logo

Clinical Trial Summary

The specific objective of this study was to investigate the sensitivity of Kisspeptin receptor 1 (KISS1R) by determining the responsiveness of GnRH neuron to kisspeptin administration across the pubertal stages and adult group through measuring plasma LH (luteinizing hormone) and testosterone concentrations.


Clinical Trial Description

No studies in humans are available regarding KISS1R signalling that, whether expression of the KISS1 or KISS1R sensitivity increases during the pubertal transition in boys. Kisspeptin regulates HPG (hypothalamic pituitary gonadal) axis by secreting GnRH that acts on the pituitary gonadotrophs to secrete LH and FSH. But in contrast to pubertal period, juvenile period kisspeptin pulsatility is reduced, that leads to low GnRH pulsatility and low level of plasma LH, FSH and testosterone. The objective of this study was to determine the response of exogenous kisspeptin in various juvenile stages up to puberty and also in the adults by measuring the level of plasma LH and testosterone. This study would help us to determine that whether there is any link between the increased sensitivity of kisspeptin signalling and puberty onset?, Or at what Tanner stage pre pubertal boys enter into puberty. ;


Study Design


Related Conditions & MeSH terms

  • Reproductive Physiological Phenomena

NCT number NCT03286517
Study type Interventional
Source Quaid-e-Azam University
Contact
Status Completed
Phase Phase 3
Start date June 26, 2014
Completion date March 5, 2015

See also
  Status Clinical Trial Phase
Recruiting NCT02010164 - CoQ10 Treatment to Improve Fertility in Elderly Patients N/A